Future studies will have to explore the potential of dehydroepiandrosterone replacement and modified delayed-release hydrocortisone to improve the prospects of patients with adrenal insufficiency.
Objective to observe the clinical therapeutic effect of Yifa compound treating female pattern hair loss and its effect on sera dihydrotestosterone (DHT) and dehydroepiandrosterone (DHEA) levels.
Objective to observe the clinical therapeutic effect of Yifa compound treating female pattern hair loss and its effect on sera dihydrotestosterone (DHT) and dehydroepiandrosterone (DHEA) levels.